visiongain Logo.png
Global Respiratory Drug Delivery Technologies market is projected to grow at a CAGR of 7.31% by 2032: Visiongain Reports Ltd
October 14, 2022 09:00 ET | Visiongain Reports Ltd
Visiongain has published a new report: Global Respiratory Drug Delivery Technologies Market, (COVID-19 Impact Analysis):- Market Segment by Product (Formulations and Devices), by Type (Dry Powder,...
visiongain Logo.png
Global biosimilar monoclonal antibodies market is projected to grow at a CAGR of 23.5% by 2032: Visiongain Reports Ltd
October 14, 2022 06:00 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled Biosimilar Monoclonal Antibodies 2022-2032. It includes profiles of Biosimilar Monoclonal Antibodies and Forecasts Market Segment by Type (Synthetic...
visiongain Logo.png
Global precision medicine market is projected to grow at a CAGR of 10.8% by 2032: Visiongain Reports Ltd
October 13, 2022 06:00 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled Precision Medicine 2022-2032. It includes profiles of precision medicine and Forecasts Market Segment by Product Type (Diagnostics, {Genetic tests, ...
visiongain Logo.png
The Global Biologics market is projected to grow at a CAGR of 8.82% By 2032: Visiongain Reports Ltd
October 12, 2022 06:00 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled the Biologics Market 2022-2032. It includes profiles of Biologics and Forecasts Market Segment by Product Type (Monoclonal Antibodies, Vaccines, Protein...
visiongain Logo.png
OTC Drugs & Dietary Supplements market is projected to grow at a CAGR of 7.90% by 2032: Visiongain Reports Ltd
October 12, 2022 05:38 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled OTC Drugs & Dietary Supplements 2022-2032. It includes profiles of OTC Drugs & Dietary Supplements and Forecasts Market Segment by Category...
visiongain Logo.png
Global Cancer Biologics Market Research Report Up to 2031: Visiongain Reports Ltd
September 09, 2022 05:00 ET | Visiongain Reports Ltd
Visiongain has launched a new report Cancer Biologics Market Report 2021-2031:Forecasts by Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), by Indication (Breast...
visiongain Logo.png
Anti-Infective Agents Market Will Grow at a CAGR of 4.3% by 2031: Visiongain Reports Ltd
September 07, 2022 04:56 ET | Visiongain Reports Ltd
Visiongain has published a new analysis of the Anti-Infective Agents Market from this year till 2031. It includes profiles of Anti-Infective Agents and Forecasts By Type (Antiviral, Antibacterial,...
visiongain Logo.png
Global Gene Therapy R&D Market Worth US$ 22,685.70 million by 2031: Visiongain Reports Ltd
September 05, 2022 07:08 ET | Visiongain Reports Ltd
Global Gene Therapy R&D Market Forecast 2021-2031: - Market Segment by Disease {Cancer, Rare Diseases (Oncologic, Non-Oncologic), Cardiovascular Diseases, Ophthalmic Diseases, Hematology,...
visiongain Logo.png
Global Anti-Infective Vaccines Market is projected to grow at a CAGR of 12.51% by 2032: Visiongain Reports Ltd
August 31, 2022 05:24 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled Anti-Infective Vaccines Market 2022-2032 - which includes profiles of Anti-infective Vaccines and Forecasts Market Segment by Disease Type {Bacterial...
visiongain Logo.png
Checkpoint Inhibitors for Treating Cancer Market Worth US$ 63,420.2 Million by 2031: Visiongain Reports Ltd
August 29, 2022 05:00 ET | Visiongain Reports Ltd
Visiongain has published a new report: Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031: Forecasts by Category (PD1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors, Cytokines...